These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11414632)

  • 1. Plasma levels of factor XIIa and factor VIIa are increased but not related in primary hyperlipidaemia.
    Cardigan RA; Crook M; Mackie IJ; Machin SJ
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):187-92. PubMed ID: 11414632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of factor VIIa, factor XIIa and beta2-glycoprotein-1 with triglyceride-rich lipoproteins in normolipidaemic subjects.
    Cardigan RA; Donohoe S; Purdy G; Mackie IJ; Machin SJ
    Blood Coagul Fibrinolysis; 1998 Jun; 9(4):323-32. PubMed ID: 9690803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients.
    Mesters RM; Mannucci PM; Coppola R; Keller T; Ostermann H; Kienast J
    Blood; 1996 Aug; 88(3):881-6. PubMed ID: 8704245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia.
    Nordøy A; Svensson B; Hansen JB
    J Thromb Haemost; 2003 Apr; 1(4):690-7. PubMed ID: 12871402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial elevation of activated factor VII in young adults.
    Kapur R; Hoffman CJ; Bhushan V; Haltin MB
    Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1327-32. PubMed ID: 8911270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure.
    Matsuo T; Koide M; Kario K; Suzuki S; Matsuo M
    Haemostasis; 1997; 27(4):163-7. PubMed ID: 9483170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of factor VIIa generation and prothrombin activation by treatment with enoxaparin in patients with unstable angina.
    Gerotziafas GT; Zafiropoulos A; Van Dreden P; Karavaggeli E; Goutzoumas N; Nikolaidis P; Combot C; Lagoudaki P; Zervas K; Arzoglou P; Samama MM
    Br J Haematol; 2003 Feb; 120(4):611-7. PubMed ID: 12588347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity.
    Altieri P; Devoto E; Spallarossa P; Rossettin P; Garibaldi S; Bertero G; Balbi M; Barsotti A; Brunelli C; Ghigliotti G
    Thromb Res; 2005; 115(1-2):65-72. PubMed ID: 15567455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Blood Coagulation System in Patients with Chronic Spontaneous Urticaria.
    Wang D; Tang H; Shen Y; Wang F; Lin J; Xu J
    Clin Lab; 2015; 61(9):1283-8. PubMed ID: 26554248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.
    Kapiotis S; Jilma B; Quehenberger P; Ruzicka K; Handler S; Speiser W
    Circulation; 1997 Jul; 96(1):19-21. PubMed ID: 9236409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies.
    Donohoe S; Quenby S; Mackie I; Panal G; Farquharson R; Malia R; Kingdom J; Machin S
    Lupus; 2002; 11(1):11-20. PubMed ID: 11898913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study on activated factors XII and VII levels during normal pregnancy.
    de Moerloose P; Amiral J; Vissac AM; Reber G
    Br J Haematol; 1998 Jan; 100(1):40-4. PubMed ID: 9450788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
    Bröijersén A; Hamsten A; Silveira A; Fatah K; Goodall AH; Eriksson M; Angelin B; Hjemdahl P
    Thromb Haemost; 1996 Aug; 76(2):171-6. PubMed ID: 8865525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway.
    Silveira A; Karpe F; Johnsson H; Bauer KA; Hamsten A
    Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1333-9. PubMed ID: 8911271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
    Kario K; Miyata T; Sakata T; Matsuo T; Kato H
    Arterioscler Thromb; 1994 Feb; 14(2):265-74. PubMed ID: 8305419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The link between high-fat meals and postprandial activation of blood coagulation factor VII possibly involves kallikrein.
    Larsen LF; Marckmann P; Bladbjerg EM; Ostergaard PB; Sidelmann J; Jespersen J
    Scand J Clin Lab Invest; 2000 Feb; 60(1):45-54. PubMed ID: 10757453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism.
    O'Donnell J; Mumford AD; Manning RA; Laffan MA
    Br J Haematol; 2001 Dec; 115(3):687-91. PubMed ID: 11736955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
    Moor E; Silveira A; van't Hooft F; Suontaka AM; Eriksson P; Blombäck M; Hamsten A
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):655-64. PubMed ID: 7749878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer.
    Gadducci A; Marrai R; Baicchi U; Gagetti O; Facchini V; Genazzani AR
    Gynecol Oncol; 1996 May; 61(2):215-7. PubMed ID: 8626135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activated factor XII in patients with hyperglycaemia and dyslipidaemia].
    Průsa R; Zadina J; Bronský J
    Vnitr Lek; 2004 Dec; 50(12):917-22. PubMed ID: 15717806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.